Myomo, Inc. Files 8-K Report
Ticker: MYO · Form: 8-K · Filed: May 6, 2024 · CIK: 1369290
| Field | Detail |
|---|---|
| Company | Myomo, Inc. (MYO) |
| Form Type | 8-K |
| Filed Date | May 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, financial-reporting
Related Tickers: MYO
TL;DR
MYO filed an 8-K, mostly financial exhibits. Keep an eye on their financials.
AI Summary
On May 6, 2024, Myomo, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating updates or disclosures related to the company's financial status. No specific material events or transactions were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Myomo, Inc.'s financial reporting and exhibits, which is important for investors to stay informed about the company's financial health and disclosures.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for financial statements and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- MYOMO, INC. (company) — Registrant
- 0000950170-24-053228 (filing_id) — Accession Number
- May 06, 2024 (date) — Date of Report
- 137 Portland St. 4th Floor Boston, Massachusetts 02114 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Myomo, Inc.?
The primary purpose of this 8-K filing for Myomo, Inc. is to report on 'Other Events' and 'Financial Statements and Exhibits'.
What is the exact name of the company filing this report?
The exact name of the company filing this report is MYOMO, INC.
On what date was this 8-K report filed?
This 8-K report was filed on May 06, 2024.
What is the Commission File Number for Myomo, Inc.?
The Commission File Number for Myomo, Inc. is 001-38109.
Where are Myomo, Inc.'s principal executive offices located?
Myomo, Inc.'s principal executive offices are located at 137 Portland St. 4th Floor, Boston, Massachusetts 02114.
Filing Stats: 486 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-05-06 08:45:40
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MYO NYSE Americ
Filing Documents
- myo-20240506.htm (8-K) — 40KB
- myo-ex99_1.htm (EX-99.1) — 27KB
- img133186882_0.jpg (GRAPHIC) — 7KB
- 0000950170-24-053228.txt ( ) — 192KB
- myo-20240506.xsd (EX-101.SCH) — 24KB
- myo-20240506_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On May 6, 2024, Myomo, Inc. (the "Company") announced that the Company has received authorizations for lump sum reimbursements from the Centers for Medicare and Medicaid Services ('CMS"), through each of their regional billing contractors known as the DME MACs, as well as a number of payments, based on the final fees for the Company's Healthcare Common Procedure Coding System ("HCSPS") codes L8701 and L8702 published by CMS, which became effective on April 1, 2024. The full text of the press release issued in conjunction with the announcement is included a Exhibit 99.1 to this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Myomo, Inc. on May 6, 2024. 104 The cover page from the Company's Form 8-K dated November 6, 2023, formatted in Inline XBRL
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MYOMO, INC. Date: May 06, 2024 By: /s/ David A. Henry David A. Henry Chief Financial Officer